People: China-Biotics Inc (CHBT.PK)


CHBT.PK on OTC Markets Group

2.10USD
18 Jun 2013
Price Change (% chg)

$0.05 (+2.44%)
Prev Close
$2.05
Open
$2.05
Day's High
$2.20
Day's Low
$2.05
Volume
2,925
Avg. Vol
5,255
52-wk High
$4.49
52-wk Low
$0.94

Search Stocks

Summary

Name Age Since Current Position

Jinan Song

 50 2006 President, Chief Executive Officer, Treasurer, Secretary, Director

Yihong Yan

 49 2012 Interim Chief Financial Officer, Chief Administrative Officer, Assistant to the General Manager

Ji Wei Chin

 55 2007 Independent Director

Ivan Chu

 31 2012 Independent Director

Wen Min Du

 44 2007 Independent Director

Luke Tang

 IR Contact Officer
» Insider Trading

Biographies

Name Description

Jinan Song

 Mr. Song Jinan is President, Chief Executive Officer, Treasurer, Secretary, Director of China-Biotics, Inc., since March 2006. His current term as director expires with the 2012 Annual Meeting of Stockholders. Mr. Song was one of the founders of Shining in 1999, and has been the principal executive officer of Shining since inception. Prior to founding Shining, Mr. Song served as the chief engineer of Sai Bao Bio-Chemical Manufacturing Corporation. Mr. Song received his Bachelor’s Degree in Polymers from the University of Hei Long Jiang and his Master’s degree in Politics and Economics from Habin Industrial University.

Yihong Yan

 Ms. Yan Yihong serves as Interim Chief Financial Officer, Chief Administrative Officer, Assistant to the General Manager of China-Biotics, Inc. Ms. Yan has served as a Director of Shining since 1999. She was appointed as the Chief Administration Officer in 2004. During the past five years, Ms. Yan has been an employee of Shining in various capacities and has, among other things, participated in formulating the company’s development plans, implemented the company’s internal control procedures and represented the company in business negotiations with relevant government authorities and other external parties.

Ji Wei Chin

 Dr. Chin Ji Wei is a Independent Director of China-Biotics, Inc., since January 2007. Dr. Chin has over 20 years of academic experience as a lecturer and researcher in the field of horticulture, where he has been focused on the areas of efficient agriculture industry and food safety. Dr. Chin has served as a Vice Principal, professor, and lecturer at Northeast Agricultural University in China since 1999. From 1985 to 1995, Dr. Chin served as a Researcher at the Northeast Agricultural University and the Northeast Agricultural Institute. Dr. Chin has Bachelors, Masters, and Doctorate degrees, all from Northeast Agricultural University. Among other professional experiences, qualifications, and skills, Dr. Chin’s experience in horticulture and agriculture industries, and in particular his focus on food safety, provide scientific knowledge and experience in the regulatory aspects of food safety that are critical to the development and distribution of the Company’s products.

Ivan Chu

 Mr. Ivan Chu serves as Independent Director of China-Biotics, Inc., since February 25, 2012. Since September 2011, Mr. Chu has been the project director for Suncorp Technology Limited (HKG: 1063), a company listed on the Hong Kong Exchange. Since July 2011, he also has served as an independent director and a member of the audit committee of CNC Holding Limited (HKG: 8356), a Hong Kong Exchange-listed company. Since September 2007, Mr. Chu also has served as the founder and executive director of HUDA Asia Investments Limited, a corporate financing company that provides services in IPO consultation, advisory services in mergers and acquisition of listed companies, management of investment funds and other securities-related services. Mr. Chu holds a Bachelor of Art (Honors) degree in Business Studies from the Bolton Institute of the University of Bolton, UK. He is certified by the Institute of Financial Accountants, UK as a Financial Accountant and by Institute of Financial Planners of Hong Kong as a Financial Planner (AFP TM). Mr. Chu is currently studying for his Master of Science degree in Finance at the National University of Ireland.

Wen Min Du

 Dr. Du Wen Min, M.D., is Independent Director of China-Biotics, Inc., since January 2007. Dr. Du has served as the Deputy Director in charge of the Centre for Adverse Drug Reactions in Shanghai since 2001. Dr. Du has also served as the Vice Chairman of Evaluation of Pharmacology & Clinical Pharmacy in Shanghai, China, and the Vice Chairman at the Centre for the Study of Liver Disease in Shanghai, China since 2006. Dr. Du has Bachelors and Masters degrees from Shanxi Medical University and a Doctorate in Medicine from Fudan University. Among other professional experiences, qualifications, and skills, Dr. Du’s experience in the pharmaceutical industry and knowledge of food and drug safety issues are critical to the development and distribution of the Company’s products.

Luke Tang

Basic Compensation

Name Fiscal Year Total

Jinan Song

 718,194

Yihong Yan

 192,027

Ji Wei Chin

 --

Ivan Chu

 --

Wen Min Du

 971,750

Luke Tang

 --
As Of 30 Mar 2012

Options Compensation

Name Options Value

Jinan Song

 0 0

Yihong Yan

 0 0

Ji Wei Chin

 0 0

Ivan Chu

 0 0

Wen Min Du

 0 0

Luke Tang

 0 0

Insider Trading

» Full list on Insider Trading
Search Stocks